Investors & media
Financial data
Find the latest press releases, financial information, and performance updates.
Transforming rare disease care
We are a global specialty biopharmaceutical company expanding possibilities for people with rare diseases. With 50 years of experience in applying our scientific expertise and unique technologies to research, we continue to develop next-generation treatments and expand our global footprint to transform the lives of patients worldwide.
Newsroom
2026.01.08
JCR Pharmaceuticals to present at the 44th Annual J.P. Morgan Healthcare Conference
2026.01.23
Briefing session material on the agreement with Italfarmaco
2026.01.16
Information on the 44th J.P. Morgan Healthcare Conference now available
2026.01.16
The 44th J.P.Morgan Healthcare Conference presentation materials
2025.12.24
Italfarmaco and JCR Pharmaceuticals announce commercialisation agreement for Givinostat in Japan and strategic collaboration in rare disease
Performance data and annual reports
JCR Pharmaceuticals (4552.T)
Tokyo Currency in JPY
695.00
+13.00
(+1.91%)
Last updated 01/23/2026 at TSE market close
Quarterly results
Annual reports
Driven by science and compassion, we tackle some of the most complex challenges in rare disease. Every solution we develop is grounded in insight into the genetic and biological foundations of the conditions we aim to treat.
Contact us
Investors & media